Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H36N2O3S |
Molecular Weight | 384.576 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
InChI
InChIKey=ALOBUEHUHMBRLE-UHFFFAOYSA-N
InChI=1S/C20H36N2O3S/c1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25/h12-15,20-21,23H,4-11,16-17H2,1-3H3
Molecular Formula | C20H36N2O3S |
Molecular Weight | 384.576 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:39:22 UTC 2023
by
admin
on
Sat Dec 16 16:39:22 UTC 2023
|
Record UNII |
2436VX1U9B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175426
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
||
|
NCI_THESAURUS |
C47793
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
||
|
WHO-ATC |
C01BD05
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
||
|
NCI_THESAURUS |
C93038
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
||
|
WHO-VATC |
QC01BD05
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C72581
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
1412
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
2436VX1U9B
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
IBUTILIDE
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
C067192
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
DB00308
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
CHEMBL533
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
41289
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000083650
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
6642
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
2436VX1U9B
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
7200
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
60753
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
m6191
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID20861271
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
SUB08102MIG
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
7926
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY | |||
|
122647-31-8
Created by
admin on Sat Dec 16 16:39:23 UTC 2023 , Edited by admin on Sat Dec 16 16:39:23 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||